EXHIBIT 6.26



                                LICENSE AGREEMENT

                                -----------------



         This License Agreement made and entered into as of June 11, 2001 by and

between Nurescell, Inc., a Nevada corporation, ("Nurescell") and Advanced

Technology Industries, Inc., a Delaware corporation, ("ATI") provides as

follows:



                                    RECITALS



         A. Nurescell has developed a novel material for shielding and

internment of radioactive materials and radioactive waste as well as providing

attenuation of X-ray energy. The material demonstrates shielding and physical

properties superior to commonly used shielding materials such as concrete,

steel, or, in some cases, lead. The material may be compounded in such a way as

to be used either in solid form or as a viscous liquid for specialized

applications. The compound may include such materials as polyester epoxy,

powdered metals, a coloring agent and polystyrenes in various combinations and

ratios. Said invention is more particularly described in United States Patent

Application No. 09/187641. Said invention is hereinafter referred to as the

"Technology."



         B. ATI desires to acquire an exclusive license of the Technology in the

Territory and upon the terms and conditions set forth herein, and Nurescell

desires to grant an exclusive license of the Technology to ATI in said Territory

and upon said terms and conditions.



         NOW THEREFORE, in consideration for the mutual covenants and agreements

contained herein and for other good and valuable consideration the receipt of

which is hereby acknowledged the parties hereto agree as follows:



1.       Grant of License.

         -----------------



         Nurescell hereby grants ATI the sole, exclusive, transferable, right

and license to market, distribute, sublicense, sell, transfer and otherwise

commercially exploit the Technology and products utilizing the Technology in the

geographical areas specified below (the "Territory") upon the terms and

conditions set forth herein. The License and rights granted to ATI pursuant

hereto, shall be conditioned upon ATI and its sub licensees, if any, thereafter

during the term of the License satisfying its obligations to Nurescell

hereunder, including without limitation, the payment of royalties and other

payments to Nurescell.



         Notwithstanding anything to the contrary contained in this Agreement

ATI shall have the right to utilize technologies and products in its business

which are similar to or related to the Technology and shall have the right to

grant its sub-licensees similar rights.



2.       Term of License.

         ----------------



         The term of this License shall be the longer of: (i) 25 years, or (ii)

the term of any patent which Nurescell now owns or may be granted in the future

on the Technology, or any modification or derivative thereof, in the United

States or any of the countries within the Territory. In the event that any court

of competent jurisdiction determines that the provision of this paragraph

violate any rule against perpetuities in said jurisdiction the term of the

License shall be automatically amended without any action of the parties to the

longest term allowable under the laws of said jurisdiction.



<PAGE>



3.       Territory

         ---------



         The Territory of the License shall be the geographical area consisting

of the European Union, the British Isles, the Russian Federation, Ubekistan,

Krygikistan, Afganistan, Pakistan, Kazakstan, Iran, Turkey, Ukraine, The Baltic

Republics, Georgia, Poland, Hungary, Czech, Slovakia, Slovenia, Egypt, South

Africa, Israel, Algeria, Libya, the UAE, Iraq, Lebanon, Saudi Arabia, and

Kuwait.



4.       Royalties

         ---------



         ATI shall pay Nurescell a royalty for the utilization of the Technology

in the amount of eight per cent (8%) of the Net Sales of the Technology by ATI.

Net Sales is hereby defined as gross sales less, discounts, rebates, credits,

returns, and freight. In the event that the Technology is incorporated in a

product the royalty shall be computed on the entire price of the product as well

as the coating or application of the product on another substance or substances.

In the case of sub-licenses the royalty shall be computed on the gross amount

received by ATI from the sub- licensee. In the event that any contract or

agreement provides for services or products in addition to the Technology or

products incorporating the Technology the royalty shall be computed only upon

that portion of the contract price attributable to the Technology or any product

incorporating the Technology and the application or coating thereof on another

Home        Intelligence        Services        Subscriptions        News        About Us

Contact Us       Terms of Use       Resend Documents       Shopping Cart

Copyright © 2008 The Consus Group LLC